Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Central Effects of Botulinum Toxin in Post-Stroke Spasticity
NCT01829763Phase 3Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Apr 2013
- Primary completion
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in spasticity, sponsored by Assistance Publique-Hôpitaux de Marseille. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT01829763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01829763.